Nosocomial Infections in the Picu



Nosocomial Infections in the Picu


Jason W. Custer

Jill Siegrist Thomas

John P. Straumanis





Since the beginning of medical practice, there have been nosocomial infections—the transmission of infection from medical practitioner or hospital environment to patient. It was not until medical procedures became increasingly invasive and the expectation that infections are curable with antibiotics that the topic of nosocomial infections became an area of interest in the medical field. Well before this, even before Louis Pasteur’s germ theory, Ignaz Semmelweis made an important clinical observation and correlation in terms of preventing nosocomial infections in 1847. He realized that his close friend and colleague died of symptoms identical to puerperal fever after his finger was cut during an autopsy on a woman who died of puerperal fever. Semmelweis further noted that a midwife-run obstetric ward had a rate for puerperal fever of only 2%. This was in stark contrast to his ward run by physicians, which had an infection rate of over 12%. The physicians performed autopsies in the morning on women who had died of puerperal fever before examining their patients on the obstetric ward. Semmelweis instituted the practice of making the students wash their hands with a chlorinated lime solution prior to examining their patients. As a result, the infection rate dropped to <2% in the following year. To this day, hand washing remains one of the most important safeguards in preventing nosocomial infection (1).

Nosocomial infections are important to consider, treat, and, most importantly, prevent in any hospital setting, especially in the ICU. Hospital-acquired infections can lead to significant morbidity and mortality. Infection-control measures can greatly impact this effect. It is equally important to prevent the infection of hospital personnel to diminish the risk of spreading infection to other patients and prevent missed days of work, which could impact the ability to staff the PICU. There are additional financial costs associated with nosocomial infections, including hospital costs, loss of productivity of healthcare personnel, and loss of income to families from missing time at work. State, Federal, and private payers have recently instituted financial penalties on hospitals when potentially preventable complications such as nosocomial infections occur during the hospital admission.




OVERVIEW AND EPIDEMIOLOGY

The CDC estimates that in the United States there are 2 million nosocomial infections annually leading to increased mortality with a conservative estimate of an additional $5.7-$6.8 billion (US dollars) in healthcare costs as a result (2). Although it may not be possible to eliminate all nosocomial infections, one-third or more could be prevented with implementation of organized infection-control programs. Given the incidence, mortality, morbidity, and cost of nosocomial infections, those which could be prevented but were not may be considered a source of medical error. Despite even the best infection-control program, there will always be the risk of nosocomial infection in the ICU due to the unique nature of the critically ill or injured patient. However, many adult and pediatric ICUs across the country have achieved zero nosocomial infections for prolonged periods of time.

The risk of nosocomial infection depends on a variety of factors. The location within the hospital plays an important role with the highest rates typically occurring in the ICU. Even the type of ICU influences the nosocomial infection rate with different rates seen in medical, surgical, trauma, burn, neurological/neurosurgical, and cardiac ICUs. The PICU is unique in that it typically cares for many or all of these subsets of patients over the pediatric age range. Another unique factor in the PICU is that different aged patients will have different incidence patterns of the various types of hospital-acquired infections. For children <5 years of age, the top three nosocomial infections are bloodstream infections (BSIs), pneumonia, and urinary tract infections (UTIs). In children between 5 and 12 years of age, the top three acquired infections are pneumonia, BSIs, and UTIs. In the adolescent population, BSIs are followed by UTIs and then pneumonia in incidence. The location of the hospital plays a role as well with an increased risk of nosocomial infection being noted in developing nations. All types of nosocomial infections when standardized to device days were increased in the ICUs of developing nations in a study by Rosenthal et al. The device utilization rates were noted to be similar in the developed and developing nation ICUs, making the increased infection rate more likely to be secondary to factors within the ICUs, hospitals, or national healthcare systems (3,4) (Table 92.1).


General Risk Factors

In addition to the location within the hospital and the type of ICU, there are general risk factors that are independent of the type of nosocomial infection. Although these risk factors can influence the likelihood of contracting a nosocomial infection, only a few can be realistically altered to impact nosocomial infection rates.

The age of the patient can affect the risk of nosocomial infection. Younger children, particularly neonates, have the highest risk in the pediatric population. The relative immaturity of the immune system at this point of life coupled with common ICU interventions, which bypass the physical barriers to infections such as skin and mucosal surfaces, is responsible for the increased risk. The use of parenteral nutrition with high glucose concentrations and lipids is an additional risk factor for infection. Premature infants are impacted the most by these factors, which explain why neonatal ICUs (NICUs) have higher nosocomial infection rates than PICUs. Patients who are immunosuppressed from chemotherapy, human immunodeficiency virus infection, or steroid use are similarly at an increased risk for developing a nosocomial infection.

Severity of illness as predicted by the Pediatric Risk of Mortality (PRISM) score has been correlated to risk of nosocomial infections. In a study by Arantes et al., a PRISM score above
13 predicted nosocomial infection in a Brazilian PICU with 78.9% sensitivity, 64.4% specificity, 21.8% positive predictive value, and 96.1% negative predictive value. Independent risk factors of developing a nosocomial infection were length of stay, prior antimicrobial therapy, and device utilization ratios, with the latter two being the best predictors of nosocomial infection risk (5).








TABLE 92.1 COMPARISON OF DEVICE USE AND RATES OF DEVICE-ASSOCIATED INFECTION IN THE ICUS OF THE US NATIONAL NOSOCOMIAL INFECTION SURVEILLANCE SYSTEM AND THE INTERNATIONAL NOSOCOMIAL INFECTION CONTROL CONSORTIUM (INICC)

































































VARIABLE


US NNIS ICUs 1992-2004


INICC ICUs 2002-2005


Rate of device usea



Mechanical ventilators


0.43 (0.23-0.62)


0.38 (0.19-0.64)



CVCs


0.57 (0.36-0.74)


0.54 (0.22-0.97)



Urinary catheters


0.78 (0.65-0.90)


0.73 (0.48-0.94)


Rate per 1000 device daysa



VAP


5.4 (1.2-7.2)


24.1 (10.0-52.7)



CVC-associated bloodstream infection


4.0 (1.7-7.6)


12.5 (7.8-18.5)



Catheter-associated UTI


3.9 (1.3-7.5)


8.9 (1.7-12.8)


Proportion of device-associated infections with resistance, %b



MRSA


59


84



Ceftriaxone-resistant Enterobacteriaceae


19


55



Ciprofloxacin-resistant P. aeruginosa


29


59



VRE


29


5


a Overall (pooled) and 10th to 90th percentile range for US NNIS teaching hospitals; overall (pooled) and range of individual countries for the INICC hospitals.


b Overall (pooled) data from NNIS, 1992-2004 (300 hospitals) and from INICC, 2002-2005. NNIS, National Nosocomial Infection Surveillance System; INICC, International Nosocomial Infection Control Consortium; UTI, urinary tract infection.


From Rosenthal VD, Maki DG, Salomao R, et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med 2006;145(8):582-91, with permission.


Data from National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470-85.


Understaffing is an independent risk factor for acquiring nosocomial infections. This is most likely owing to the fact that adherence to good hand hygiene has been shown to be inversely correlated to workload. This has been noted for BSIs and ventilator-associated pneumonia (VAP). Understaffing increases workload and therefore nosocomial infection risk. In a study of US NICUs, understaffing by 0.11 of a nurse per infant increased the risk of infection from 9% to 14%. Understaffing by 0.22 nurses per infant increased the risk to 21% (Fig. 92.1). Simply increasing staffing with temporary staff does not reverse this trend. This is likely due to disruption of the normal communication within the interdisciplinary team and familiarity with best practices (6,7,8).






FIGURE 92.1. Predicted risk-adjusted infection by nursing unit understaffing amount. (Modified from Rogowski JA, Staiger D, Patrick T, et al. Nurse staffing and NICU infection rates. JAMA Pediatr 2013;167(5):444-50.)

Red blood cell transfusions have been found to be an independent risk factor for the development of nosocomial infections in critically ill adult ICU patients. In a single-center prospective, observational study, the incidence of nosocomial infection was 14.3% in transfused patients and 5.8% in nontransfused patients. Each unit of packed red blood cells administered increased the risk of developing a nosocomial infection by 9.7%. Increasing severity of illness did not affect the risk of developing a nosocomial infection. However, within each quartile of probability of survival, the transfused group had a higher rate of nosocomial infection, which was significant in all but the most severely ill patients with a probability of survival <25%. Those patients with >25% probability of survival had higher mortality rates, longer ICU stays, and longer hospitalizations compared to nontransfused patients. A pediatric study also found the increased risk of nosocomial infection associated with transfusion. However, a dose response was not seen with increasing number of units transfused, but mortality was greater in those receiving three or more units (9,10) (Fig. 92.2).






FIGURE 92.2. Nosocomial infection (NI) rates adjusted for probability of survival (POS). The overall rate of NI in transfused patients was significantly higher than in nontransfused patients (p < 0.0001; Cochran-Mantel-Haenszel test). Numbers within the bars indicate the number of patients with NI/total in each group. The p values beneath each bar refer to the significance level of the within-group comparisons (Student’s t-tests). (From Taylor RW, O’Brien J, Trottier SJ, et al. Red blood cell transfusions and nosocomial infections in critically ill patients. Crit Care Med 2006;34(9):2302-8, with permission.)



Isolation Precautions

image Prevention of nosocomial illness can be, in large part, facilitated through the use of isolation precautions. These precautions can be divided into two categories: standard and transmission-based precautions. Standard precautions should be used at all times and are designed to prevent the practitioner from coming in contact with potentially infectious bodily fluids. The most important standard precaution is hand hygiene. Soap and water hand washing is considered the gold standard. Use of waterless antiseptic agents is appropriate unless there is the presence of visible dirt, proteinaceous bodily fluids such as blood, or when contamination with spores is likely. Soap and water are necessary under these circumstances. Hand hygiene must be done both before and after patient contact even if gloves are worn. Barriers such as gloves, masks, eye protection, and nonsterile gowns should be worn when contact with bodily fluids or secretions are likely.

Transmission-based precautions are aimed at protection against transmission of infectious organisms from patients with documented or suspected infection as well as those colonized with specific organisms. These additional precautions are over and above the standard precautions and are based on route of transmission: contact, droplet, and airborne transmission. Common organisms requiring each type of isolation are listed in Table 92.2. Contact precautions are used for a wide variety of organisms that spread by direct contact with the patient or indirect contact via fomites such as toys, stethoscopes, and unwashed hands. Contact isolation should include singlepatient rooms or cohorting, gowns, and gloves in addition to standard precautions. Droplet precautions are used for organisms that spread short distances, <3 feet away, from the patient via coughing or sneezing. Droplet isolation includes single-patient rooms or cohorting of patients with the same organism. Healthcare providers should wear a mask with an eye shield in addition to following standard precautions. Some organisms such as adenovirus and influenza require both contact and droplet precautions. Airborne precautions include additional safeguards to be taken for organisms transmitted by air currents such as tuberculosis, measles, and varicella. Patients should be in private rooms with negative air flow. For measles and varicella isolation, susceptible healthcare providers should avoid contact if possible. For other organisms requiring airborne precautions, a fitted respirator should be worn while in the patient’s room. Isolation should be based on the clinical symptoms or conditions present at admission and should always begin even before the organism is isolated (11) (Table 92.3).








TABLE 92.2 TRANSMISSION-BASED ISOLATION RECOMMENDATIONS FOR SPECIFIC INFECTIOUS ORGANISMS AND ILLNESSES




























































CONTACT PRECAUTIONS


DROPLET PRECAUTIONS


AIRBORNE PRECAUTIONS


Colonization or infection with a multidrug-resistant bacteria


Adenovirus


Diphtheria (pharyngeal)


Mycobacterium tuberculosis


Clostridium difficile


Haemophilus influenzae type B (invasive)


Rubeola virus (measles)


Conjunctivitis, viral and hemorrhagic


Hemorrhagic Fever viruses


Varicella-Zoster virus


Diphtheria (cutaneous)


Influenza


SARS


Enteroviruses


Mumps


Viral hemorrhagic fevers


Escherichia coli O157:H7 and other Shiga toxin-producing E. coli


Mycoplasma pneumoniae


N. meningitidis (invasive)


Hepatitis A virus


Parvovirus B19 during the phase of illness before onset of rash in immunocompetent patients


Herpes simplex (neonatal, mucocutaneous or cutaneous)


Herpes zoster (localized with no evidence of dissemination)


Pertussis


Plague (pneumonic)


Human meta-pneumovirus


Rhinovirus


Impetigo


RSV (consider during community outbreaks)


Major (noncontained) abscesses, cellulitis, or decubitus ulcer


Rubella


Parainfluenza virus


SARS


Pediculosis (lice)


RSV


Streptococcal pharyngitis, pneumonia, or scarlet fever


Rotavirus


Viral hemorrhagic fevers


Salmonella species


Scabies


Shigella species


S. aureus (cutaneous or draining wounds)


Viral hemorrhagic fevers (Ebola, Lassa, or Marburg)


Some organisms may include more than one type of isolation. This list is not all inclusive.Data from American Academy of Pediatrics. Infection Control for Hospitalized Children. Red Book: 2012 Report of the Committee on Infectious Diseases. Pickering LK, ed. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2012.


For protection against airborne infections, the selection of the correct type of respirator and having a proper fit are crucial. Respirators can be either air-supplying or air-purifying. The air-supplying respirators provide the greatest protection but are expensive and require high amounts of maintenance to assure proper functioning. Air-purifying respirators filter air through a cartridge, which must be selected based on the type of hazard (bacterial or chemical) to be exposed to. These
respirators are protective but not to the same degree as the air-supplying devices. Disposable respirators are air-purifying or filtering devices. The N95 respirators are the most commonly used ones in healthcare settings. The letter designates the mask’s reaction to oil. N means not oil proof. If exposed to oil, the filtering efficiency of the mask may not be maintained. There are also oil-resistant masks and oil-proof masks, designated R and P, respectively. The number indicates the filtering efficiency of the mask with an adequate seal. The number 95 identifies the mask as having the ability to filter at least 95% of particles with a median diameter of 0.3 µm or greater. Most respirators have limitations when used by individuals with facial hair, and specialized devices may be necessary (12).








TABLE 92.3 CLINICAL SYNDROMES OR CONDITIONS WARRANTING PRECAUTIONS IN ADDITION TO STANDARD PRECAUTIONS TO PREVENT TRANSMISSION OF EPIDEMIOLOGICALLY IMPORTANT PATHOGENS PENDING CONFIRMATION OF DIAGNOSISa






CLINICAL SYNDROME OR CONDITIONb


POTENTIAL PATHOGENS

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 4, 2016 | Posted by in CRITICAL CARE | Comments Off on Nosocomial Infections in the Picu

Full access? Get Clinical Tree

Get Clinical Tree app for offline access